TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Regenerative Medicine 1.2 Key Market Segments 1.2.1 Regenerative Medicine Segment by Type 1.2.2 Regenerative Medicine Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Regenerative Medicine Market Overview 2.1 Global Regenerative Medicine Market Size (M USD) Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Regenerative Medicine Market Competitive Landscape 3.1 Global Regenerative Medicine Revenue Market Share by Manufacturers (2017-2022) 3.2 Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Manufacturers Regenerative Medicine Sales Sites, Area Served, Service Type 3.4 Regenerative Medicine Market Competitive Situation and Trends 3.4.1 Regenerative Medicine Market Concentration Rate 3.4.2 Global 5 and 10 Largest Regenerative Medicine Players Market Share by Revenue 3.4.3 Mergers & Acquisitions, Expansion 4 Regenerative Medicine Value Chain Analysis 4.1 Regenerative Medicine Value Chain Analysis 4.2 Midstream Market Analysis 4.3 Downstream Customer Analysis 5 The Development and Dynamics of Regenerative Medicine Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 Mergers & Acquisitions 5.5.2 Expansions 5.5.3 Collaboration/Supply Contracts 5.6 Industry Policies 6 Regenerative Medicine Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Regenerative Medicine Market Size Market Share by Type (2017-2022) 6.3 Global Regenerative Medicine Sales Growth Rate by Type (2017-2022) 7 Regenerative Medicine Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Regenerative Medicine Market Size (M USD) by Application (2017-2022) 7.3 Global Regenerative Medicine Sales Growth Rate by Application (2017-2022) 8 Regenerative Medicine Market Segmentation by Region 8.1 Global Regenerative Medicine Market Size by Region 8.1.1 Global Regenerative Medicine Market Size by Region 8.1.2 Global Regenerative Medicine Market Share by Region 8.2 North America 8.2.1 North America Regenerative Medicine Market Size by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Regenerative Medicine Market Size by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Regenerative Medicine Market Size by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Regenerative Medicine Market Size by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Regenerative Medicine Market Size by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 J and J (DePuy Synthes) 9.1.1 J and J (DePuy Synthes) Regenerative Medicine Basic Information 9.1.2 J and J (DePuy Synthes) Regenerative Medicine Product Overview 9.1.3 J and J (DePuy Synthes) Regenerative Medicine Product Market Performance 9.1.4 J and J (DePuy Synthes) Business Overview 9.1.5 J and J (DePuy Synthes) Regenerative Medicine SWOT Analysis 9.1.6 J and J (DePuy Synthes) Recent Developments 9.2 Medtronic 9.2.1 Medtronic Regenerative Medicine Basic Information 9.2.2 Medtronic Regenerative Medicine Product Overview 9.2.3 Medtronic Regenerative Medicine Product Market Performance 9.2.4 Medtronic Business Overview 9.2.5 Medtronic Regenerative Medicine SWOT Analysis 9.2.6 Medtronic Recent Developments 9.3 Zimmer Biomet 9.3.1 Zimmer Biomet Regenerative Medicine Basic Information 9.3.2 Zimmer Biomet Regenerative Medicine Product Overview 9.3.3 Zimmer Biomet Regenerative Medicine Product Market Performance 9.3.4 Zimmer Biomet Business Overview 9.3.5 Zimmer Biomet Regenerative Medicine SWOT Analysis 9.3.6 Zimmer Biomet Recent Developments 9.4 Stryker 9.4.1 Stryker Regenerative Medicine Basic Information 9.4.2 Stryker Regenerative Medicine Product Overview 9.4.3 Stryker Regenerative Medicine Product Market Performance 9.4.4 Stryker Business Overview 9.4.5 Stryker Regenerative Medicine SWOT Analysis 9.4.6 Stryker Recent Developments 9.5 Allergan(Acelity) 9.5.1 Allergan(Acelity) Regenerative Medicine Basic Information 9.5.2 Allergan(Acelity) Regenerative Medicine Product Overview 9.5.3 Allergan(Acelity) Regenerative Medicine Product Market Performance 9.5.4 Allergan(Acelity) Business Overview 9.5.5 Allergan(Acelity) Regenerative Medicine SWOT Analysis 9.5.6 Allergan(Acelity) Recent Developments 9.6 MiMedx Group 9.6.1 MiMedx Group Regenerative Medicine Basic Information 9.6.2 MiMedx Group Regenerative Medicine Product Overview 9.6.3 MiMedx Group Regenerative Medicine Product Market Performance 9.6.4 MiMedx Group Business Overview 9.6.5 MiMedx Group Recent Developments 9.7 Organogenesis 9.7.1 Organogenesis Regenerative Medicine Basic Information 9.7.2 Organogenesis Regenerative Medicine Product Overview 9.7.3 Organogenesis Regenerative Medicine Product Market Performance 9.7.4 Organogenesis Business Overview 9.7.5 Organogenesis Recent Developments 9.8 Fujifilm Cellular Dynamics 9.8.1 Fujifilm Cellular Dynamics Regenerative Medicine Basic Information 9.8.2 Fujifilm Cellular Dynamics Regenerative Medicine Product Overview 9.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Product Market Performance 9.8.4 Fujifilm Cellular Dynamics Business Overview 9.8.5 Fujifilm Cellular Dynamics Recent Developments 9.9 Osiris Therapeutics 9.9.1 Osiris Therapeutics Regenerative Medicine Basic Information 9.9.2 Osiris Therapeutics Regenerative Medicine Product Overview 9.9.3 Osiris Therapeutics Regenerative Medicine Product Market Performance 9.9.4 Osiris Therapeutics Business Overview 9.9.5 Osiris Therapeutics Recent Developments 9.10 Vcanbio 9.10.1 Vcanbio Regenerative Medicine Basic Information 9.10.2 Vcanbio Regenerative Medicine Product Overview 9.10.3 Vcanbio Regenerative Medicine Product Market Performance 9.10.4 Vcanbio Business Overview 9.10.5 Vcanbio Recent Developments 9.11 CCBC 9.11.1 CCBC Regenerative Medicine Basic Information 9.11.2 CCBC Regenerative Medicine Product Overview 9.11.3 CCBC Regenerative Medicine Product Market Performance 9.11.4 CCBC Business Overview 9.11.5 CCBC Recent Developments 9.12 Cytori 9.12.1 Cytori Regenerative Medicine Basic Information 9.12.2 Cytori Regenerative Medicine Product Overview 9.12.3 Cytori Regenerative Medicine Product Market Performance 9.12.4 Cytori Business Overview 9.12.5 Cytori Recent Developments 9.13 Celgene 9.13.1 Celgene Regenerative Medicine Basic Information 9.13.2 Celgene Regenerative Medicine Product Overview 9.13.3 Celgene Regenerative Medicine Product Market Performance 9.13.4 Celgene Business Overview 9.13.5 Celgene Recent Developments 9.14 Vericel Corporation 9.14.1 Vericel Corporation Regenerative Medicine Basic Information 9.14.2 Vericel Corporation Regenerative Medicine Product Overview 9.14.3 Vericel Corporation Regenerative Medicine Product Market Performance 9.14.4 Vericel Corporation Business Overview 9.14.5 Vericel Corporation Recent Developments 9.15 Guanhao Biotech 9.15.1 Guanhao Biotech Regenerative Medicine Basic Information 9.15.2 Guanhao Biotech Regenerative Medicine Product Overview 9.15.3 Guanhao Biotech Regenerative Medicine Product Market Performance 9.15.4 Guanhao Biotech Business Overview 9.15.5 Guanhao Biotech Recent Developments 9.16 Mesoblast 9.16.1 Mesoblast Regenerative Medicine Basic Information 9.16.2 Mesoblast Regenerative Medicine Product Overview 9.16.3 Mesoblast Regenerative Medicine Product Market Performance 9.16.4 Mesoblast Business Overview 9.16.5 Mesoblast Recent Developments 9.17 AMAG Pharmaceuticals (CBR) 9.17.1 AMAG Pharmaceuticals (CBR) Regenerative Medicine Basic Information 9.17.2 AMAG Pharmaceuticals (CBR) Regenerative Medicine Product Overview 9.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Product Market Performance 9.17.4 AMAG Pharmaceuticals (CBR) Business Overview 9.17.5 AMAG Pharmaceuticals (CBR) Recent Developments 9.18 ViaCord 9.18.1 ViaCord Regenerative Medicine Basic Information 9.18.2 ViaCord Regenerative Medicine Product Overview 9.18.3 ViaCord Regenerative Medicine Product Market Performance 9.18.4 ViaCord Business Overview 9.18.5 ViaCord Recent Developments 9.19 CordLife 9.19.1 CordLife Regenerative Medicine Basic Information 9.19.2 CordLife Regenerative Medicine Product Overview 9.19.3 CordLife Regenerative Medicine Product Market Performance 9.19.4 CordLife Business Overview 9.19.5 CordLife Recent Developments 9.20 Integra LifeSciences 9.20.1 Integra LifeSciences Regenerative Medicine Basic Information 9.20.2 Integra LifeSciences Regenerative Medicine Product Overview 9.20.3 Integra LifeSciences Regenerative Medicine Product Market Performance 9.20.4 Integra LifeSciences Business Overview 9.20.5 Integra LifeSciences Recent Developments 9.21 Nuvasive 9.21.1 Nuvasive Regenerative Medicine Basic Information 9.21.2 Nuvasive Regenerative Medicine Product Overview 9.21.3 Nuvasive Regenerative Medicine Product Market Performance 9.21.4 Nuvasive Business Overview 9.21.5 Nuvasive Recent Developments 9.22 Cook Biotech 9.22.1 Cook Biotech Regenerative Medicine Basic Information 9.22.2 Cook Biotech Regenerative Medicine Product Overview 9.22.3 Cook Biotech Regenerative Medicine Product Market Performance 9.22.4 Cook Biotech Business Overview 9.22.5 Cook Biotech Recent Developments 9.23 Japan Tissue Engineering 9.23.1 Japan Tissue Engineering Regenerative Medicine Basic Information 9.23.2 Japan Tissue Engineering Regenerative Medicine Product Overview 9.23.3 Japan Tissue Engineering Regenerative Medicine Product Market Performance 9.23.4 Japan Tissue Engineering Business Overview 9.23.5 Japan Tissue Engineering Recent Developments 10 Regenerative Medicine Regional Market Forecast 10.1 Global Regenerative Medicine Market Size Forecast 10.2 Global Regenerative Medicine Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Regenerative Medicine Market Size Forecast by Country 10.2.3 Asia Pacific Regenerative Medicine Market Size Forecast by Region 10.2.4 South America Regenerative Medicine Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Regenerative Medicine by Country 11 Market Segmentation & Size Forecast (2023-2028) 11.1 Global Regenerative Medicine Market Forecast by Type (2023-2028) 11.2 Global Regenerative Medicine Market Forecast by Application (2023-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Regenerative Medicine Market Size (M USD) Comparison by Region (M USD) Table 5. Global Regenerative Medicine Revenue (M USD) by Manufacturers (2017-2022) Table 6. Global Regenerative Medicine Revenue Share by Manufacturers (2017-2022) Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2021) Table 8. Manufacturers Regenerative Medicine Sales Sites and Area Served Table 9. Manufacturers Regenerative Medicine Service Type Table 10. Global Regenerative Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 11. Mergers & Acquisitions, Expansion Plans Table 12. Value Chain Map of Regenerative Medicine Table 13. Midstream Market Analysis Table 14. Downstream Customer Analysis Table 15. Key Development Trends Table 16. Driving Factors Table 17. Regenerative Medicine Market Challenges Table 18. Market Restraints Table 19. Global Regenerative Medicine Market Size by Type (M USD) Table 20. Global Regenerative Medicine Market Size (M USD) by Type (2017-2022) Table 21. Global Regenerative Medicine Market Size Share by Type (2017-2022) Table 22. Global Regenerative Medicine Sales Growth Rate by Type (2017-2022) Table 23. Global Regenerative Medicine Sales (K Units) by Application Table 24. Global Regenerative Medicine Market Size by Application Table 25. Global Regenerative Medicine Sales by Application (2017-2022) & (M USD) Table 26. Global Regenerative Medicine Market Share by Application (2017-2022) Table 27. Global Regenerative Medicine Sales Growth Rate by Application (2017-2022) Table 28. Global Regenerative Medicine Market Size by Region (2017-2022) & (M USD) Table 29. Global Regenerative Medicine Market Share by Region (2017-2022) Table 30. North America Regenerative Medicine Market Size by Country (2017-2022) & (M USD) Table 31. Europe Regenerative Medicine Market Size by Country (2017-2022) & (M USD) Table 32. Asia Pacific Regenerative Medicine Market Size by Region (2017-2022) & (M USD) Table 33. South America Regenerative Medicine Market Size by Country (2017-2022) & (M USD) Table 34. Middle East and Africa Regenerative Medicine Market Size by Region (2017-2022) & (M USD) Table 35. J and J (DePuy Synthes) Regenerative Medicine Basic Information Table 36. J and J (DePuy Synthes) Regenerative Medicine Product Overview Table 37. J and J (DePuy Synthes) Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 38. J and J (DePuy Synthes) Business Overview Table 39. J and J (DePuy Synthes) Regenerative Medicine SWOT Analysis Table 40. J and J (DePuy Synthes) Recent Developments Table 41. Medtronic Regenerative Medicine Basic Information Table 42. Medtronic Regenerative Medicine Product Overview Table 43. Medtronic Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 44. Medtronic Business Overview Table 45. Medtronic Regenerative Medicine SWOT Analysis Table 46. Medtronic Recent Developments Table 47. Zimmer Biomet Regenerative Medicine Basic Information Table 48. Zimmer Biomet Regenerative Medicine Product Overview Table 49. Zimmer Biomet Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 50. Zimmer Biomet Business Overview Table 51. Zimmer Biomet Regenerative Medicine SWOT Analysis Table 52. Zimmer Biomet Recent Developments Table 53. Stryker Regenerative Medicine Basic Information Table 54. Stryker Regenerative Medicine Product Overview Table 55. Stryker Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 56. Stryker Business Overview Table 57. Stryker Regenerative Medicine SWOT Analysis Table 58. Stryker Recent Developments Table 59. Allergan(Acelity) Regenerative Medicine Basic Information Table 60. Allergan(Acelity) Regenerative Medicine Product Overview Table 61. Allergan(Acelity) Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 62. Allergan(Acelity) Business Overview Table 63. Allergan(Acelity) Regenerative Medicine SWOT Analysis Table 64. Allergan(Acelity) Recent Developments Table 65. MiMedx Group Regenerative Medicine Basic Information Table 66. MiMedx Group Regenerative Medicine Product Overview Table 67. MiMedx Group Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 68. MiMedx Group Business Overview Table 69. MiMedx Group Recent Developments Table 70. Organogenesis Regenerative Medicine Basic Information Table 71. Organogenesis Regenerative Medicine Product Overview Table 72. Organogenesis Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 73. Organogenesis Business Overview Table 74. Organogenesis Recent Developments Table 75. Fujifilm Cellular Dynamics Regenerative Medicine Basic Information Table 76. Fujifilm Cellular Dynamics Regenerative Medicine Product Overview Table 77. Fujifilm Cellular Dynamics Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 78. Fujifilm Cellular Dynamics Business Overview Table 79. Fujifilm Cellular Dynamics Recent Developments Table 80. Osiris Therapeutics Regenerative Medicine Basic Information Table 81. Osiris Therapeutics Regenerative Medicine Product Overview Table 82. Osiris Therapeutics Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 83. Osiris Therapeutics Business Overview Table 84. Osiris Therapeutics Recent Developments Table 85. Vcanbio Regenerative Medicine Basic Information Table 86. Vcanbio Regenerative Medicine Product Overview Table 87. Vcanbio Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 88. Vcanbio Business Overview Table 89. Vcanbio Recent Developments Table 90. CCBC Regenerative Medicine Basic Information Table 91. CCBC Regenerative Medicine Product Overview Table 92. CCBC Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 93. CCBC Business Overview Table 94. CCBC Recent Developments Table 95. Cytori Regenerative Medicine Basic Information Table 96. Cytori Regenerative Medicine Product Overview Table 97. Cytori Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 98. Cytori Business Overview Table 99. Cytori Recent Developments Table 100. Celgene Regenerative Medicine Basic Information Table 101. Celgene Regenerative Medicine Product Overview Table 102. Celgene Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 103. Celgene Business Overview Table 104. Celgene Recent Developments Table 105. Vericel Corporation Regenerative Medicine Basic Information Table 106. Vericel Corporation Regenerative Medicine Product Overview Table 107. Vericel Corporation Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 108. Vericel Corporation Business Overview Table 109. Vericel Corporation Recent Developments Table 110. Guanhao Biotech Regenerative Medicine Basic Information Table 111. Guanhao Biotech Regenerative Medicine Product Overview Table 112. Guanhao Biotech Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 113. Guanhao Biotech Business Overview Table 114. Guanhao Biotech Recent Developments Table 115. Mesoblast Regenerative Medicine Basic Information Table 116. Mesoblast Regenerative Medicine Product Overview Table 117. Mesoblast Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 118. Mesoblast Business Overview Table 119. Mesoblast Recent Developments Table 120. AMAG Pharmaceuticals (CBR) Regenerative Medicine Basic Information Table 121. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product Overview Table 122. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 123. AMAG Pharmaceuticals (CBR) Business Overview Table 124. AMAG Pharmaceuticals (CBR) Recent Developments Table 125. ViaCord Regenerative Medicine Basic Information Table 126. ViaCord Regenerative Medicine Product Overview Table 127. ViaCord Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 128. ViaCord Business Overview Table 129. ViaCord Recent Developments Table 130. CordLife Regenerative Medicine Basic Information Table 131. CordLife Regenerative Medicine Product Overview Table 132. CordLife Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 133. CordLife Business Overview Table 134. CordLife Recent Developments Table 135. Integra LifeSciences Regenerative Medicine Basic Information Table 136. Integra LifeSciences Regenerative Medicine Product Overview Table 137. Integra LifeSciences Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 138. Integra LifeSciences Business Overview Table 139. Integra LifeSciences Recent Developments Table 140. Nuvasive Regenerative Medicine Basic Information Table 141. Nuvasive Regenerative Medicine Product Overview Table 142. Nuvasive Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 143. Nuvasive Business Overview Table 144. Nuvasive Recent Developments Table 145. Cook Biotech Regenerative Medicine Basic Information Table 146. Cook Biotech Regenerative Medicine Product Overview Table 147. Cook Biotech Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 148. Cook Biotech Business Overview Table 149. Cook Biotech Recent Developments Table 150. Japan Tissue Engineering Regenerative Medicine Basic Information Table 151. Japan Tissue Engineering Regenerative Medicine Product Overview Table 152. Japan Tissue Engineering Regenerative Medicine Revenue (M USD) and Gross Margin (2017-2022) Table 153. Japan Tissue Engineering Business Overview Table 154. Japan Tissue Engineering Recent Developments Table 155. Global Regenerative Medicine Market Size Forecast by Region (M USD) Table 156. North America Regenerative Medicine Market Size Forecast by Country (2023-2028) & (M USD) Table 157. Europe Regenerative Medicine Market Size Forecast by Country (2023-2028) & (M USD) Table 158. Asia Pacific Regenerative Medicine Market Size Forecast by Region (2023-2028) & (M USD) Table 159. South America Regenerative Medicine Market Size Forecast by Country (2023-2028) & (M USD) Table 160. Middle East and Africa Regenerative Medicine Market Size Forecast by Country (2023-2028) & (M USD) Table 161. Global Regenerative Medicine Market Size Forecast by Type (2023-2028) & (M USD) Table 162. Global Regenerative Medicine Market Size Forecast by Application (2023-2028) & (M USD) LIST OF FIGURES Figure 1. Industrial Chain of Regenerative Medicine Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Regenerative Medicine Market Size (M USD), 2017-2028 Figure 5. Global Regenerative Medicine Market Size (M USD) (2017-2028) Figure 6. Evaluation Matrix of Segment Market Development Potential (Type) Figure 7. Evaluation Matrix of Segment Market Development Potential (Application) Figure 8. Evaluation Matrix of Regional Market Development Potential Figure 9. Regenerative Medicine Market Size (M USD) by Country (M USD) Figure 10. Global Regenerative Medicine Revenue Share by Manufacturers in 2021 Figure 11. Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 12. The Global 5 and 10 Largest Players: Market Share by Regenerative Medicine Revenue in 2021 Figure 13. Evaluation Matrix of Segment Market Development Potential (Type) Figure 14. Global Regenerative Medicine Market Share by Type Figure 15. Market Size Share of Regenerative Medicine by Type (2017-2022) Figure 16. Market Size Market Share of Regenerative Medicine by Type in 2021 Figure 17. Global Regenerative Medicine Sales Growth Rate by Type (2017-2022) Figure 18. Global Regenerative Medicine Market Share by Application Figure 19. Global Regenerative Medicine Market Share by Application (2017-2022) Figure 20. Global Regenerative Medicine Market Share by Application in 2021 Figure 21. Global Regenerative Medicine Sales Growth Rate by Application (2017-2022) Figure 22. Global Regenerative Medicine Market Share by Region (2017-2022) Figure 23. North America Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 24. North America Regenerative Medicine Market Share by Country in 2021 Figure 25. U.S. Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 26. Canada Regenerative Medicine Market Size (M USD) and Growth Rate (2017-2022) Figure 27. Mexico Regenerative Medicine Market Size (Units) and Growth Rate (2017-2022) Figure 28. Europe Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 29. Europe Regenerative Medicine Market Share by Country in 2021 Figure 30. Germany Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 31. France Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 32. U.K. Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 33. Italy Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 34. Russia Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 35. Asia Pacific Regenerative Medicine Market Size and Growth Rate (M USD) Figure 36. Asia Pacific Regenerative Medicine Market Share by Region in 2021 Figure 37. China Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 38. Japan Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 39. South Korea Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 40. India Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 41. Southeast Asia Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 42. South America Regenerative Medicine Market Size and Growth Rate (M USD) Figure 43. South America Regenerative Medicine Market Share by Country in 2021 Figure 44. Brazil Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 45. Argentina Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 46. Columbia Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 47. Middle East and Africa Regenerative Medicine Market Size and Growth Rate (M USD) Figure 48. Middle East and Africa Regenerative Medicine Market Share by Region in 2021 Figure 49. Saudi Arabia Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 50. UAE Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 51. Egypt Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 52. Nigeria Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 53. South Africa Regenerative Medicine Market Size and Growth Rate (2017-2022) & (M USD) Figure 54. Global Regenerative Medicine Market Size Forecast by Value (2017-2028) & (M USD) Figure 55. Global Regenerative Medicine Market Share Forecast by Type (2023-2028) Figure 56. Global Regenerative Medicine Market Share Forecast by Application (2023-2028)

•J and J (DePuy Synthes) •Medtronic •Zimmer Biomet •Stryker •Allergan(Acelity) •MiMedx Group •Organogenesis •Fujifilm Cellular Dynamics •Osiris Therapeutics •Vcanbio •CCBC •Cytori •Celgene •Vericel Corporation •Guanhao Biotech •Mesoblast •AMAG Pharmaceuticals (CBR) •ViaCord •CordLife •Integra LifeSciences •Nuvasive •Cook Biotech •Japan Tissue Engineering